Which test is NOT typically necessary for a client suspected of having BPH?

In evaluating a client suspected of having benign prostatic hyperplasia (BPH), certain diagnostic tests are more commonly utilized than others. Cystoscopy, which involves the insertion of a scope into the bladder through the urethra, is not typically necessary for initial diagnosis or management of BPH. Instead, it is generally reserved for cases where there are complications or when other conditions need to be evaluated, such as bladder tumors, strictures, or other obstructive pathologies.

In contrast, the prostate-specific antigen (PSA) test is valuable for monitoring prostate health and ruling out prostate cancer, making it commonly ordered in cases of suspected BPH. A transrectal ultrasound can provide information about the size of the prostate and guide treatment options by enabling visualization of the prostate, which is important in the management of BPH. Additionally, performing a urine analysis for infection helps rule out urinary tract infections as a cause of urinary symptoms, which can overlap with those of BPH. Hence, cystoscopy is not necessary for the routine assessment of BPH, making it the correct choice in this context.